We describe what we believe is the first reported case of simultaneoushighly invasivecutaneousand laryngopharyngeal zygomycosis in a non-neutropenic, nondiabetic but immunosuppressed patient with prostatecancer. An invasive fungal process wasnot suspected until late in the patient'shospital course; when it was, a tracheotomy and direct laryngoscopicbiopsieswereperformed. Unresectable invasive zygomycosis with Rhizopus rhizopo diformis wasdiagnosed. Thepatient wasmanaged with liposomal amphotericin B initially and laterwithpalliativemedical therapy until he died. This case emphasizesthe needfor a rapid and specific diagnosis with timely introduction ofappropriateantifu ngalmanagement,particularly now that voriconazole is frequently used as empiric prophylaxis aga inst aspergillosis in high-risk patients.
Introduction
Zygom ycosis occur s as an opportunistic infection in immunocompromised and diabetic patients with acidos is, hematologic malignancy, or end-stage renal disease and in th ose who are taking immunos uppressa nt th erapy after undergoing solid-organ transplan tation. Such an infection can occur in th e sinocerebral stru ctures, respi- ratory tra ct,lun gs,and gastro intestinal system, and it can occur as a disseminated illness. Invasive rhinocerebra l zygomycosis is a well-known entity; hosts with variable immunologic functi on (i.e.,patientswith rheumatologic disease who are treated with steroi ds) may present with prima ry cutaneo us or invasive zygom ycosis. We describe an atypical case of devastatin g head and neck zygomycosis. To th e best of our knowledge, this is th e first reported case of lar yngeal zygomycosis in a patient with a non -neutrop enicsolid tumor and the first reported case of simultaneo us laryngeal and cutaneous zygomycosis.
Case report
A 79-year-old man with a history of prostate cancer pr esent ed for placeme nt of percuta neo us nephrostomy tubes. However, tube placement was com plicated by the onse t ofpurulence. He becam e septic and required fluid resuscitation, and his leu kocyte count rose from 7,900 to 33,000/fll. He develop ed acute renal failure, with a peak seru m creatinine level of 2.8 mg/dl and a carbon dioxide (CO) level of 10 mmollL. His serum glucose level dro pp ed acutely from 126 to 64 mg/dl. He was not kn own to be in iron overloa d; to th e contrar y,th e results of baseline iron studies were low: a serum iron level of l l ug/dl, 9% satur ation, a total iron-bin ding capacity of 121 ug/dl, and a transferrin level of 97 mg/dl. Th e patient's history was significant for a prostatectom y 12 years earlier and ur eth ral obstruction of 8 years' duration . In additio n to hormon al ablation, he had received 6 courses of docetaxel (last administered 5 weeks prior to pr esentation) and 5 months of pred- nison e dosed at 10 mg daily. It was believed th at th e patient had continu ed prednison e th erapy right up un til pr esentati on. He also had coron ary ar tery disease and congestive heart failur e.
For his current conditio n, the patient was treated with broad-spectrum antibiotics and vasopressors. Blood cultures yielded Enterobacter cloacae. He develop ed azotemia and hypo xia secondary to volume overload. He was intubated within 13 hours, and he required central veno venous hemofiltration for volum e overload and metabolic acidosis. On day 1 after intubation, a blood gas evaluation revealed a serum pH of 7.28 and a partial CO 2 (pC0 2 ) level of 32 mm Hg.
On day 7 after intubation, the patient developed multiple er ythematous, scaling lesions around hi s mouth and no se. These lesions were initially thought to be h erp etic, and topical acyclovir was administered . Fur ther evaluation of th e pati en t's oropha rynx revealed th e pr esence of necrotic annular lesion s on the hard and soft palate, on th e left nasal ala, beneath th e right nostril, and within th e right aspect of the columella. Scrapings of th e lip lesions and a tr acheal aspira te were cultured. Max illofacia l computed tomography (CT) detected no evide nce of nasal or sinus disease; th oracic and abdo m ina l CTs dem on st rated pulmonary edem a and an irregularity of th e stoma ch th at ra ised concern s about a possible m ass or ulcerative process. Meanwhile, the patient's ren al functi on improved, and he was extubated on day 9.
Two days later, the pati ent developed intermittent fever and a necrotic-appearing escha r on the skin and vermillion of the lips an d simil ar lesions on the pal ate Volume 87, Number 3 mucosa (figure 1).Mild biph asic st ridor was noted. Flexible fiberoptic laryngoscop y revealed mu cosal edema, ery thema, and abunda nt thick, black crus ting in the hypopharynx, supraglott is, and visible glott is. The left vocal fold was paretic. Cultures of th e tracheal aspi rate m aterial taken 5 days earlier and of th e lip taken 1 day earlier grew a zygomycetous fun gus. Based on the app earance of th e patien t's skin and oro pha ryngeal lesion s and th e culture result s, we initiated th er apy with lipo somal am photericin B (5 mg/kg).
Th e next day, new perioral lesions were noted. An awake tracheotomy, dir ect laryngoscopy,bronchoscopy, and directed biopsies wer e performed to establish the extent of disease. Th e results of fro zen -section analy sis of the biopsies of th e lip, soft pal ate , and larynx were all consistent with zygomycosis.Specifically, permanent sections confirmed th e pr esence of broad-b ranching, nonsept ate hyphae with extensive tissue necrosi s and ulceration, as seen with invasive disease (figure 2). Th e tracheobronchial mu cosa appea red normal on bronchoscopy. Resection of th e lip and laryngeal lesions was not feasible in view of th e extent of involveme n t at multiple sites in th e up per aero digest ive tract. Altho ug h th e abdo m inal CT had indicated possible involveme nt of th e sto mac h, no further evalua tion was performed.
On postop erative day 2, th e pati ent experienced progressive respiratory failur e despite supportive the rap y and an increase in th e dosage ofliposomal amphotericin Bto 7.5 mg/kg (cumulative dose: 3.0 g).His familyelected not to advance his level of care, and th e patient died shortly th ereafter. The famil y declined an autopsy.
Fo ur cultures were positive for a zygomycetous fungus that was subsequently identified as Rhizopusrhizopodi-[armis.The culture findings on the tracheal aspir ate did not raise any alarm until the cultures from the lip scrapings were repo rted as pos itive for th e same organ ism. Two days after the initiation ofliposoma l amp hotericin B, the tracheal cultures revealed the persistence of the organism.
Discussion
Invasive zygomycosis is a well-defi ned clinica l syndrome associ ated with fungi in the genera Rhizopus, Mucor,Absidia,Rhizomucor,and Cunninghamella.The infection in our patient was cause d by R rhizopodiformis, ubi quit ou s environmental fungi th at may be the source of nosocomial outbreaks secondary to environmental contamination.The clinical presentations of infection by fungi of these genera are consistently th e same . In 1978, Keys et al pub lished a classic report of nosocomial Rhizopus infection in immunocompromised host s, including neonates who had been exposed to an adhesive tape (Elastoplast) used to secure en dotracheal tu bes. 1 The following year, Everett et al reviewed cases of localized postoperative Rhizopus wound infections that were traced to the use of Elastoplast bandages contaminated with Rhizopus? These examples support the recommenda tion that we must specia te the pathogen in order to monit or for potential nosocomial outbreaks .
While cases of primary cut aneous zygomycosis!" and pr imary tracheal zygomycosis' " have been reported, to th e best of our knowledge, ours is th e first reported case of both cutaneous and extensive tra nsglottic zygomycosis.
Wehypothesize that the cutaneous infection occurred first. As was the case in some of th e earlier reports, our pat ient's dermatologic infection might have been caused by contaminated endotracheal tape; even tho ugh the chronology of our cultures did not support this, it is possible that the early skin lesions were not prominent. If the cutaneo us infection did ind eed man ifest first, it then spread to involve the aerodigestive tract. In terms of its clinical course, the infection became aggressive at the time antifungal therapy was initiated, as new cutaneous lesions were noted within 24 hours after the patient's initial evaluatio n by th e infectiou s disease con sult ant s. The patien t was not neutropenic, and he had no history of diabetes , but he had recentl y received chemotherapy, including a low-d ose cor ticosteroid for prostate cancer. The combination ofrecent chemotherapy,his azotemia, " an d his metabolic acidosis? likely predisposed him to invasive zygomycosis.
A striki ng feature of this case was the duration of smoldering subclinical infection, as the pat ient's endotracheal cult ur es grew the filamentous organism at least 5 days before he experienced clinical decline. In 2000, Kontoyiannis et al suggested that a respiratory culture positive for a zygomycete was typicall y associated with a steady decline to rapi d death. "
Successful treatme nt of tr acheal zygomycosis requ ires surg ical debridement with parenteral an tifungal therapy" There is a single report of cutaneous zygomycosis treated wit hout surgica l debridement of lesions,' bu t invasive disease requires early recogni tion, surg ical debrid em ent, and liposom al am pho ter icin B or posaconazole. Fluco nazo le, vorico nazole, and the echinocandins have no therapeutic activity against fungi of the order Mucorales.
Posaconazole, a new broad-spectrum triazole,and terbin afine, an allylamine antifunga l, have in vitro activity against these fungi .The activity of posaconazole against zygomycosis varies in animal models; R rhizopodiformis is susceptib le to posaconazole in a dose-dependent fashion. II The successful use of posacon azole against zygomycetes has been described only in case reports." This drug was used as successful salvage therapy in a solid-organ transplant recipient with zygomycosis who did not respond to therapy wit h ampho ter icin Until recently, no microbiologic techniques were available to facilitate the prompt diagnosis of zygomycosis. But tod ay, th e development of a multiplex polymerase chain reaction assay (PCR) 14 and PCRbased restriction fragment length polymorphism 's to identify pathogenic Rhizopus species in human tissue offers hope that rapid diagnosis-and hence better survival-may be possible.
Our case highlights the importance of the prompt recognition of the patient's perioral and lip lesions as suspicious for zygomycosis. Early th erap y with liposomal amphotericin B or posaconazole an d surgical debridement might have altered the course of infection. Accurate diagnosis is dependent on culture or histopathology from biopsy, as zygomycosis must be distinguished from other hyphal fungal infections (e.g., aspergillosis). It is imperative that clinicians have a high index of suspicion and the ability to recogni ze the early signs of cutaneous zygomyco sis, even in the absence of diabetic ketoacidosis or overt immunosuppression. Growth of a filamentous organism from endotracheal aspirate or sputum in an intubated patient also warrants further prompt investigation.
The etiology ofinvasive fung al infections in hospitalized immunocompromised patients isevolving.Because aspergillosis isstillthe most common filam entous fun gal infection, voriconazole recently replaced amphotericin B as the first-line treatment for febrile neutropenia and as empiric therapy in tertiary car e centers. Since then, however, an increase in the incidence of zygomycosis has been reported. The switch to voriconazole has been implicated, because this drug does not have activity against the zygomycetes.16·18
Describing their prospective studyof27 pati entswith hematologic mal ignancies with and without a history of stem-cell transplant, Kontoyiannis et al recently reported that the use ofvoriconazole prophylaxisand the presence of sinusitis were strongly associ ated with zygomycosis on multivariate analysis when patients with zygomycosis were compared with those with aspergillosis (odds ratio: 76.72; 95% confidence interval: 6.48 to 908.15; P= 0.001 ).19Of20 cases speciated by morpholog y and sequencing identification, there were 14cases ofdefinite and 1 probable Rhizopus, 4 cases of Mucor, and 1 case of Cunninghamella; this dist ribution implies a lack of voriconazole activity in th e entire group.
Overall, there appeared to be a trend toward an increase in the incidence of zygomyco sis in the 1990s in Volume 87, Number 3 cance r cent ers befo re the routine use of voriconazole." Thi s trend may continue with th e development of new antifungal drugs.
